Yinzhu Jin

Featured in: Favicon

wiley.com (+1) Favicon

biomedcentral.com Favicon

unirioja.es Favicon

jrheum.org Favicon

qualitysafety.bmj.com Favicon

arthritis-research.biomedcentral.com Favicon

dialnet.unirioja.es

Articles

Real‐World Treatment Effectiveness of Disease‐Modifying Antirheumatic Drugs by Serostatus Among Patients With Rheumatoid Arthritis

Sep 30, 2023 | acrjournals.onlinelibrary.wiley.com | Yinzhu Jin |Jun Liu |Rishi J. Desai |Seoyoung C. Kim

Serostatus may be associated with different responses to disease-modifying antirheumatic drugs (DMARDs) in patients with rheumatoid arthritis (RA). Whether a different treatment strategy is needed for the seropositive versus seronegative RA subsets remains unclear because of the limited evidence.
Risk of Infection in Children With Psoriasis Receiving Treatment With Ustekinumab, Etanercept, or Methotrexate Before and After Labeling Expansion

Aug 22, 2023 | dialnet.unirioja.es | Maria C. Schneeweiss |Timothy Savage |Richard Wyss |Yinzhu Jin

Risk of Infection in Children With Psoriasis Receiving Treatment With Ustekinumab, Etanercept, or Methotrexate Before and After Labeling ExpansionAutores: Maria C. Schneeweiss, Timothy J. Savage, Richard Wyss, Yinzhu Jin, Katharina Schoder, Joseph F. Merola, Robert Sidbury, Theresa Oduol, Sebastian Schneeweiss, Robert J. GlynnLocalización: JAMA Dermatology, ISSN 2168-6068, Vol. 159, Nº. 3, 2023, págs.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →